Subsequently, we investigated the association between HIF-2A expression and clinicopathological features by categorizing the ccRCC sample cohort based on the WHO/ISUP stage, tumor T stage, and distant metastasis and compared HIF-2A levels (Supplementary Table S9). This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.